New hope for easing physical and emotional pain after pregnancy loss
NCT ID NCT06029673
Summary
This study tested whether a single dose of the medication cabergoline could prevent painful breast engorgement and milk leakage after a second-trimester abortion or pregnancy loss. Researchers compared cabergoline to a placebo in 69 participants who were 16-20 weeks pregnant. The goal was to see if the medication could reduce physical discomfort and emotional distress during recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATION SUPPRESSED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Planned Parenthood - San Jose Central Health Center
San Jose, California, 95126, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.